Albireo Pharma Inc (ALBO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
06-2016 | 03-2016 | 12-2015 | 09-2015 | 06-2015 | |
Sales | 7,973 | 124 | 0 | 0 | 0 |
Gross Profit | 7,973 | 124 | N/A | N/A | N/A |
Operating Expenses | 6,031 | 2,748 | 0 | 0 | 6,579 |
Operating Income | 1,942 | -2,624 | N/A | N/A | -6,579 |
Interest Expense | 512 | 526 | 0 | 0 | 0 |
Other Income | 709 | -89 | -3,207 | 0 | 137 |
Pre-tax Income | 2,139 | -3,239 | -3,207 | 0 | -6,442 |
Income Tax | N/A | N/A | 8 | N/A | 20 |
Net Income Continuous | 2,139 | -3,239 | N/A | N/A | -6,462 |
Net Income | $2,139 | $-3,239 | $N/A | $N/A | $-6,462 |
EPS Basic Total Ops | 7.42 | -12.20 | -1.50 | N/A | -3.60 |
EPS Basic Continuous Ops | 7.43 | -12.18 | N/A | N/A | -3.60 |
EPS Diluted Total Ops | 0.69 | -12.20 | -1.50 | N/A | -3.60 |
EPS Diluted Continuous Ops | 0.69 | -12.18 | N/A | N/A | -3.60 |
EBITDA(a) | $2,225 | $-2,343 | $N/A | $N/A | $-6,532 |